Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research.

Vekris A, Meynard D, Haaz MC, Bayssas M, Bonnet J, Robert J.

Cancer Res. 2004 Jan 1;64(1):356-62.

2.

Determination of drug interactions occurring with the metabolic pathways of irinotecan.

Charasson V, Haaz MC, Robert J.

Drug Metab Dispos. 2002 Jun;30(6):731-3.

PMID:
12019202
3.

Hepatic extraction, metabolism, and biliary excretion of irinotecan in the isolated perfused rat liver.

Farabos C, Haaz MC, Gires P, Robert J.

J Pharm Sci. 2001 Jun;90(6):722-31.

PMID:
11357175
4.
5.

Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38.

Dodds HM, Haaz MC, Riou JF, Robert J, Rivory LP.

J Pharmacol Exp Ther. 1998 Jul;286(1):578-83.

PMID:
9655905
6.

Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.

Haaz MC, Rivory L, Riché C, Vernillet L, Robert J.

Cancer Res. 1998 Feb 1;58(3):468-72.

7.

Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.

Rivory LP, Haaz MC, Canal P, Lokiec F, Armand JP, Robert J.

Clin Cancer Res. 1997 Aug;3(8):1261-6.

8.
9.

Glucuronidation of SN-38, the active metabolite of irinotecan, by human hepatic microsomes.

Haaz MC, Rivory L, Jantet S, Ratanasavanh D, Robert J.

Pharmacol Toxicol. 1997 Feb;80(2):91-6.

PMID:
9060040
10.

Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients.

Rivory LP, Riou JF, Haaz MC, Sable S, Vuilhorgne M, Commerçon A, Pond SM, Robert J.

Cancer Res. 1996 Aug 15;56(16):3689-94.

11.

Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenase.

Haaz MC, Fischel JL, Formento P, Renée N, Etienne MC, Milano G.

Cancer Chemother Pharmacol. 1996;38(1):52-8.

PMID:
8603452
12.

Understanding open-to-buy, Part 2.

Haaz M.

Hosp Gift Shop Manage. 1989 Jan;7(1):28-9. No abstract available.

PMID:
10291228
13.

Understanding open-to-buy. Part 1.

Haaz M.

Hosp Gift Shop Manage. 1988 Dec;6(12):31-2. No abstract available.

PMID:
10302981

Supplemental Content

Support Center